The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of regulation 48 (infringement notices)U.K.

This section has no associated Explanatory Memorandum

21.  In regulation 48(3) M1, omit—

(a)sub-paragraph (a); and

(b)sub-paragraph (c), and the “and” immediately preceding it.

Commencement Information

I1Reg. 21 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations

M1Regulation 48 was amended by S.I. 2006/1928 and 2012/1916.